Calcineurin Inhibitor-Free Graft-Versus-Host Disease (GVHD) Prophylaxis in Hematopoietic Cell Transplantation (HCT) with Myeloablative Conditioning Regimens (MAC) and HLA-Matched Donors: Results of the BMT CTN 1301 Progress II Trial
暂无分享,去创建一个
N. Geller | M. Perales | H. Heslop | M. Pasquini | R. Soiffer | Juan Wu | L. Muffly | S. Devine | B. Logan | E. Nemecek | S. Giralt | S. Solomon | L. Luznik | V. Ho | J. Schetelig | M. Litzow | L. Shune | S. Vasu | L. O’Donnell | M. Horowitz | A. Mendizabal | R. Palencia